Back to Search
KATHRYN FERRANTE, DMD
DMD
Dentist
NPI: 1699295352Individual
Specialties, Licenses & Credentials
General Practice Dentistry
Dentist — General Practice
Code: 1223G0001X
DN1857597(MA)
DentistPrimary
Dentist
Code: 122300000X
DN1857597(MA)
Research & Publications (13)
Analysis of factors that modify susceptibility and rate of progression in amyotrophic lateral sclerosis (ALS).
PMID 16963407·Amyotroph Lateral Scler·2006
4-observational
Detection of serum reverse transcriptase activity in patients with ALS and unaffected blood relatives.
PMID 15699374·Neurology·2005
4-observational
A phase I and pharmacologic study of the matrix metalloproteinase inhibitor CP-471,358 in patients with advanced solid tumors.
PMID 15592721·Cancer Chemother Pharmacol·2005
3-trial
A phase I open label study of the farnesyltransferase inhibitor CP-609,754 in patients with advanced malignant tumors.
PMID 15534083·Clin Cancer Res·2004
3-trial
Creatine therapy provides neuroprotection after onset of clinical symptoms in Huntington's disease transgenic mice.
PMID 12787055·J Neurochem·2003
7-preclinical
Therapeutic effects of coenzyme Q10 and remacemide in transgenic mouse models of Huntington's disease.
PMID 11880489·J Neurosci·2002
7-preclinical
Phase I and pharmacologic study of OSI-774, an epidermal growth factor receptor tyrosine kinase inhibitor, in patients with advanced solid malignancies.
PMID 11432895·J Clin Oncol·2001
3-trial
Increases in cortical glutamate concentrations in transgenic amyotrophic lateral sclerosis mice are attenuated by creatine supplementation.
PMID 11299300·J Neurochem·2001
7-preclinical
Dichloroacetate exerts therapeutic effects in transgenic mouse models of Huntington's disease.
PMID 11456300·Ann Neurol·2001
7-preclinical
Effects of an inhibitor of poly(ADP-ribose) polymerase, desmethylselegiline, trientine, and lipoic acid in transgenic ALS mice.
PMID 11259130·Exp Neurol·2001
7-preclinical
Phase I and pharmacokinetic study of BMS-184476, a taxane with greater potency and solubility than paclitaxel.
PMID 11331328·J Clin Oncol·2001
3-trial
Creatine increase survival and delays motor symptoms in a transgenic animal model of Huntington's disease.
PMID 11447996·Neurobiol Dis·2001
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 976 MAIN ST
WALTHAM, MA 02451 - Phone
- (781) 894-3143
Quick Facts
- NPI
- 1699295352
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 2
- Publications
- 13
Are you this provider?
Claim Your Profile